POWAY, CA--(Marketwire -01/27/12)- Vet-Stem, Inc. today
announced that over 8,000 animals have now been treated with
Vet-Stem cell
therapy.

Vet-Stem
began providing stem cells to veterinarians in 2004
and has now provided stem cells for the treatment of over
8,000 animals. Vet-Stem was the first company to introduce
rapid turnaround stem cell services in the US. After
providing stem cells for thousands of horses, Vet-Stem
pioneered stem
cell therapy in dogs and cats and is now the world
leader in Regenerative Veterinary Medicine™. The rapid
adoption of stem cell therapy by equine veterinarians and
horse owners provided a springboard for use in small animal
veterinary medicine.

Greater than 75% of horses treated with Vet-Stem cell therapy
for tendon and ligament injuries are able to return to their
previous level of performance. Dog owners report that greater
than 80% of dogs treated with Vet-Stem cell therapy have an
improved quality of life.

"We are proud that so many dog, horse, and cat owners as well
as veterinarians have placed their trust in Vet-Stem cell
therapy. We feel a great sense of accomplishment knowing that
there are now over 8,000 horse and pet owners who have
experienced the benefit of stem cell technology. This
practical and beneficial application of technology puts stem
cell therapy into the present day instead of a future
theoretical concept," said Bob Harman, DVM, MPVM, Founder and
CEO of Vet-Stem.

Vet-Stem is now working with small animal veterinarians to
develop other life-saving uses for stem cell therapy for
injuries and diseases that currently have few treatment
options.

More information about Vet-Stem can be found at http://www.Vet-Stem.com^[1]

About Vet-Stem, Inc.:
Vet-Stem, Inc. was formed in
2002 to bring regenerative medicine to the veterinary
profession. This privately held company delivers stem cell
and related services and products to veterinarians to treat
diseases in dogs, cats and horses. These technologies utilize
the natural healing properties inherent in all animals to
reduce pain and improve the quality of life of our animal
companions. Published studies have confirmed that
adipose-derived stem cells can dramatically improve the
healing of injuries and diseases that have had very few
treatment options in the past.

Vet-Stem holds the exclusive worldwide veterinary rights to
the Artecel (University of Pittsburgh) and University of
California adipose stem cell patent portfolio of over 55
issued patents.